Please provide your email address to receive an email when new articles are posted on . The first randomized study of photon and proton radiation for breast cancer showed both modalities preserve ...
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up We investigated the SEER-Medicare linked database, identifying patients with ...
Proton therapy provides a safer, targeted alternative to conventional radiation for some breast cancer patients. Radiation therapy has improved dramatically over the past few decades to allow for more ...
Results from the health-related quality of life (HRQOL) analysis of the University of Pennsylvania and RTOG Foundation RadComp study indicated that both photon and proton radiation treatment options ...
Matthew Poppe, MD, physician-scientist at Huntsman Cancer Institute and associate professor of radiation oncology at the University of Utah, received a grant from the National Cancer Institute (NCI) ...
The trial, one of several NRG Oncology ongoing clinical trials across various malignancies within the National Clinical Trials Network (NCTN) that compare photon versus proton radiation therapy ...
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment ...
Within the next month, providers at Fred Hutch – Proton Therapy will be able to offer advanced X-ray radiation, called TrueBeam photon radiation, to those patients who will benefit from this modality.
Children with craniopharyngiomas have better neurocognitive outcomes when they are treated with proton-beam radiation instead of the usual approach ― traditional photon radiation ― without loss of ...
MIDDLETON, Wis., Sept. 28, 2025 /PRNewswire/ -- Leo Cancer Care is using ASTRO 2025 to launch Grace™, the company's upright photon therapy system. Grace is named after American computer scientist and ...
In a phase 3 trial of patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) resulted in noninferior progression-free survival and better overall survival than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results